In fact, XRCC4 polymorphisms were specifically identified as having the potential to be novel useful markers for "primary prevention and anticancer intervention" in the case of urothelial bladder cancer.
De feito, os polimorfismos de XRCC4 foron identificados especificamente como características co potencial de ser novos marcadores útiles para a "prevención primaria e intervención anticancro" no caso do cancro de vexiga urotelial.